|
1
|
Vokes EE, Liebowitz DN and Weichselbaum
RR: Nasopharyngeal carcinoma. Lancet. 350:1087–1091. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wei WI and Sham JST: Nasopharyngeal
carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lo KW, To KF and Huang DP: Focus on
nasopharyngeal carcinoma. Cancer Cell. 5:423–428. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Spano JP, Busson P, Atlan D, Bourhis J,
Pignon JP, Esteban C and Armand JP: Nasopharyngeal carcinomas: An
update. Eur J Cancer. 39:2121–2135. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cho WC: Nasopharyngeal carcinoma:
Molecular biomarker discovery and progress. Mol Cancer. 6:12007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Franklin S and Vondriska TM: Genomes,
proteomes, and the central dogma. Circ Cardiovasc Genet. 4:5762011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Balakirev ES and Ayala FJ: Pseudogenes:
Are they ‘junk’ or functional DNA? Annu Rev Genet. 37:123–151.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Quan M, Chen J and Zhang D: Exploring the
secrets of long noncoding RNAs. Int J Mol Sci. 16:5467–5496. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fatima R, Akhade VS, Pal D and Rao SM:
Long noncoding RNAs in development and cancer: Potential biomarkers
and therapeutic targets. Mol Cell Ther. 3:52015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nie Y, Liu X, Qu S, Song E, Zou H and Gong
C: Long non-coding RNA HOTAIR is an independent prognostic marker
for nasopharyngeal carcinoma progression and survival. Cancer Sci.
104:458–464. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao Y, Li J and Wang L: Large intervening
non-coding RNA HOTAIR is an indicator of poor prognosis and a
therapeutic target in human cancers. Int J Mol Sci. 15:18985–18999.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Zhang P, Wang L, Piao HL and Ma
L: Long non-coding RNA HOTAIR in carcinogenesis and metastasis.
Acta Biochim Biophys Sin (Shanghai). 46:1–5. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Weber DG, Johnen G, Casjens S, Bryk O,
Pesch B, Jöckel KH, Kollmeier J and Brüning T: Evaluation of long
noncoding RNA MALAT1 as a candidate blood-based biomarker for the
diagnosis of non-small cell lung cancer. BMC Res Notes. 6:5182013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tripathi V, Shen Z, Chakraborty A, Giri S,
Freier SM, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A and
Prasanth KV: Long noncoding RNA MALAT1 controls cell cycle
progression by regulating the expression of oncogenic transcription
factor B-MYB. PLoS Genet. 9:e10033682013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao W, Chan JY and Wong TS: Differential
expression of long noncoding RNA in primary and recurrent
nasopharyngeal carcinoma. Biomed Res Int. 2014:4045672014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hila L, Farah F, Ayari H, Ferjaoui M,
Dehria W and Ben Jilani S: Epidemiological study,
immunohistochemistry and in situ hybridization studies of
nasopharyngeal carcinomas: A Tunisian report. Pathol Biol (Paris).
57:427–429. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jia WH and Qin HD: Non-viral environmental
risk factors for nasopharyngeal carcinoma: A systematic review.
Semin Cancer Biol. 22:117–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kimura Y, Suzuki D, Tokunaga T,
Takabayashi T, Yamada T, Wakisaka N, Yoshizaki T, Murata H, Miwa K,
Shoujaku H, et al: Epidemiological analysis of nasopharyngeal
carcinoma in the central region of Japan during the period from
1996 to 2005. Auris Nasus Larynx. 38:244–249. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou X, Cui J, Macias V, Kajdacsy-Balla
AA, Ye H, Wang J and Rao PN: The progress on genetic analysis of
nasopharyngeal carcinoma. Comp Funct Genomics. 575132007.PubMed/NCBI
|
|
24
|
Young LS and Dawson CW: Epstein-Barr virus
and nasopharyngeal carcinoma. Chin J Cancer. 33:581–590.
2014.PubMed/NCBI
|
|
25
|
Lee AW, Lin JC and Ng WT: Current
management of nasopharyngeal cancer. Semin Radiat Oncol.
22:233–244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang W, Wang L, Zheng F, Zou R, Xie C,
Guo Q, Hu Q, Chen J, Yang X, Yao H, et al: Long noncoding RNA
expression signatures of metastatic nasopharyngeal carcinoma and
their prognostic value. Biomed Res Int. 2015:6189242015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maruyama R and Suzuki H: Long noncoding
RNA involvement in cancer. BMB Rep. 45:604–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yarmishyn AA and Kurochkin IV: Long
noncoding RNAs: A potential novel class of cancer biomarkers. Front
Genet. 6:1452015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan TH, Yang H, Jiang JH, Lu SW, Peng CX,
Que HX, Lu WL and Mao JF: Prognostic significance of long
non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
Int J Clin Exp Pathol. 8:4126–4131. 2015.PubMed/NCBI
|
|
32
|
Chang L, Li C, Lan T, Wu L, Yuan Y, Liu Q
and Liu Z: Decreased expression of long non-coding RNA GAS5
indicates a poor prognosis and promotes cell proliferation and
invasion in hepatocellular carcinoma by regulating vimentin. Mol
Med Rep. 13:1541–1550. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li L, Li X, The E, Wang LJ, Yuan TY, Wang
SY, Feng J, Wang J, Liu Y, Wu YH, et al: Low expression of
lncRNA-GAS5 is implicated in human primary varicose great saphenous
veins. PLoS One. 10:e01205502015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hodge JC, Pearce KE, Wang X, Wiktor AE,
Oliveira AM and Greipp PT: Molecular cytogenetic analysis for TFE3
rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part
sarcoma: Validation and clinical experience with 75 cases. Mod
Pathol. 27:113–127. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu L, Yang R, Gan W, Chen X, Qiu X, Fu K,
Huang J, Zhu G and Guo H: Xp11.2 translocation renal cell
carcinomas in young adults. BMC Urol. 15:572015. View Article : Google Scholar : PubMed/NCBI
|
